Answers are grounded in this paper and cite their sources.
Kaposi sarcoma (KS) is an angioproliferative malignancy associated with human herpesvirus (HHV)‐8. Four variants are classically described, distinguished by clinical course and populations affected.1 Epidemic or acquired immune deficiency syndrome (AIDS)‐related KS is the most aggressive type and occurs in HIV‐positive patients. Classic KS affects elderly men of eastern European or Mediterranean descent, while endemic KS affects younger adults and children in African countries. Finally, the iatrogenic variant arises in immunosuppressed patients, such as organ‐transplant recipients. Another recently proposed subtype, termed ‘nonepidemic KS’, appears to have a predilection for HIV‐negative men who have sex with men (MSM).2 3 However, this subtype remains undercharacterized. We describe five cases of nonepidemic KS (Table 1). Characteristics of the male patients with Kaposi sarcoma. Characteristics of the male patients with Kaposi sarcoma. All patients were HIV‐negative men who reported having male sexual partners (Table 1). Two patients were taking antiretroviral therapy for pre‐exposure prophylaxis. No patient had clinical evidence of immunocompromise. Four reported at least partial Eastern European or Mediterranean ethnicity. Mean age of diagnosis and symptom onset was about 55 years. All diagnoses were histologically proven. The initial presenting lesions for four patients were located on the legs (Fig. 1). No patient had symptoms suggesting visceral or systemic involvement of their disease. Some of the patients underwent dedicated imaging for staging, all of which was negative. All were treated with a combination of local resection and topical treatments without systemic therapy. No patient has developed further cancers since diagnosis (average follow‐up time of 1.8 years). (a) Brown–purple macules on the right lateral ankle; (b) raised brown–purple papule with surrounding erythema on the heel. There have been multiple reports of KS cases that do not fit into the conventional subtypes of KS, particularly HIV‐negative MSM, prompting the designation of nonepidemic KS as a separate clinical entity. However, this is still largely under‐recognized among physicians. Our cases are demographically and clinically similar to previously reported cases of nonepidemic KS. Generally, nonepidemic KS is skin‐limited and follows an indolent course.3 4 Lanternier et al.2 reported that this group may be at increased risk for lymphoproliferative disease; however, we did not observe this in our patients during a limited period of clinical follow‐up. The majority of our patients reported at least partial Mediterranean or Eastern European background. This demographic is usually associated with classic KS; however, the average age of onset for our cases was almost 10 years younger than that reported for classic KS,1 differentiating this group from prototypical classic KS. We speculate that factors contributing to nonepidemic KS may be an additive risk factor for KS in other epidemiologically at‐risk populations. One possible mechanism is the increased prevalence of HHV‐8 infection amongst MSM, leading to higher rates of KS, even in immunocompetent men.4 5 However, further studies are needed to better elucidate the underlying pathophysiology of nonepidemic KS. Our case series further supports the observation that MSM may be at risk for KS even without HIV infection, and in fact, individuals of this population may be at greater risk if they also have other possibly predisposing characteristics. Increased awareness of this clinical subgroup among dermatology clinicians is critically important for prompt diagnosis, treatment and surveillance. Conflict of interest: the authors declare that they have no conflicts of interest.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: